New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

September 2005

September 6

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) Injection

Date of Approval: September 6, 2005
Company: Merck & Co., Inc.
Treatment for: Mumps Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Varicella-Zoster -- Prophylaxis

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) FDA Approval History

September 28

Angeliq (drospirenone and estradiol) Tablets

Date of Approval: September 28, 2005
Company: Berlex, Inc.
Treatment for: Postmenopausal Symptoms

Angeliq is a hormone replacement therapy containing estradiol and the progestin drospirenone, a hormone that counters the excess water and sodium buildup that is a side effect of estradiol. Angeliq is used to treat moderate to severe menopausal symptoms, such as hot flashes and vaginal dryness.

Angeliq (drospirenone and estradiol) FDA Approval History

February 29

Angeliq (drospirenone and estradiol)

New Formulation Approved: February 29, 2012

Angeliq (drospirenone and estradiol) FDA Approval History

Hide
(web5)